Patents by Inventor Frederick Libert

Frederick Libert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7285390
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: October 23, 2007
    Assignee: Euroscreen S.A.
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Patent number: 6930174
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: August 16, 2005
    Assignee: Euroscreen, s.a.
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Patent number: 6800447
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: October 5, 2004
    Assignee: Euroscreen S.A.
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Publication number: 20040110127
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Application
    Filed: September 12, 2003
    Publication date: June 10, 2004
    Applicant: Euroscreen
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Patent number: 6692938
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: February 17, 2004
    Assignee: Euroscreen, S.A.
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Patent number: 6448375
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: September 10, 2002
    Assignee: Euroscreen S.A.
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Publication number: 20020110870
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO: 1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Application
    Filed: August 24, 2001
    Publication date: August 15, 2002
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Publication number: 20020110805
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO: 1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Application
    Filed: August 24, 2001
    Publication date: August 15, 2002
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert
  • Publication number: 20020106742
    Abstract: A peptide has an amino acid sequence having more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. A nucleic acid molecule has more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. Ligands, anti-ligands, cells vectors relating to the peptide and/or nucleic acid molecule are also used.
    Type: Application
    Filed: August 24, 2001
    Publication date: August 8, 2002
    Inventors: Michel Samson, Marc Parmentier, Gilbert Vassart, Frederick Libert